American Electric deal a ‘big win’ for Bloom Energy, says Evercore ISI
Evercore ISI reiterated an Outperform rating and $22 price target on Bloom Energy (BE) after American Electric Power (AEP) said it has an ...
TradeWinds11h
Don’t hold your breath: OSG’s Sam Norton weighs in on Jones Act tanker replacement
OSG is one of the the largest movers of Jones Act and US-flag petroleum cargoes, but Norton’s view on replacement of tankers ...
Prudential upgraded to In Line from Underperform at Evercore ISI
Evercore ISI analyst Thomas Gallagher upgraded Prudential (PRU) to In Line from Underperform with a price target of $140, up from $117. The ...
Elon Musk's $2 trillion spending cut goal is very ambitious, says Evercore ISI's Sarah Bianchi
Sarah Bianchi, Evercore ISI chief strategist of public policy, joins CNBC's 'The Exchange' to discuss the so-called DOGE ...
Trump's economic policy to be net reflationary, fewer rate cuts expected, says Evercore ISI's Guha
Krishna Guha, Evercore ISI vice chairman, joins CNBC's 'Squawk Box' to discuss expectations for PPI, how a new Trump ...
"Strong case" for re-valuation higher of life insurance sector: Evercore ISI
Investing.com - A "strong case" can be made for a re-valuation higher of the life insurance sector, according to analysts at ...
Target, BJ placed on Negative Tactical list at Evercore
Evercore ISI analysts on Thursday issued a negative tactical trading call on shares of Target Corporation (NYSE: TGT) and BJ's Wholesale Club Holdings (NYSE: BJ).
Target is on watch after Evercore ISI warns of a negative earnings reaction
Evercore ISI initiates negative call on Target Corporation (TGT) ahead of earnings report, forecasting Q3 sales deceleration ...
S&P 500 Forecast: Inflation Data Sparks Fed Rate Cut Hopes – What’s Next?
Inflation data bolsters Fed rate cut hopes, lifting US stock sentiment. Will S&P 500 and Nasdaq extend the post-election ...
AbbVie's disappointing schizophrenia drug trial bodes well for rival Bristol Myers, analysts say
AbbVie Inc.'s disappointing trial results for its new schizophrenia drug bode well for rival Bristol Myers Squibb Co., analysts said.
AOL3d
The FOMO market is back: Morning Brief
election results. "Exuberance lies ahead," Julian Emanuel, who leads the equity, derivatives, and quantitative strategy team ...
Aquis Exchange Agrees to $267 Million Takeover by SIX Exchange Group
Aquis Exchange said it agreed to a 207 million-pound ($267.5 million) takeover offer from SIX Exchange Group. The London-based exchange said Monday that the offer valued its shares at 727 pence each, ...